Skip Navigation



European Heart Journal Advance Access published online on August 31, 2007

European Heart Journal, doi:10.1093/eurheartj/ehm361
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/20/2465    most recent
ehm361v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Konduracka, E.
Right arrow Articles by Piwowarska, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Konduracka, E.
Right arrow Articles by Piwowarska, W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: no evidence for its occurrence in the era of intensive insulin therapy

Ewa Konduracka1, Andrzej Gackowski1, Pawel Rostoff1,*, Danuta Galicka-Latala2, Wieslaw Frasik3 and Wieslawa Piwowarska1

1 Department of Coronary Disease, Jagiellonian University School of Medicine, ul. Pradnicka 80, Krakow 31-202, Poland
2 Department of Metabolic Diseases, Jagiellonian University School of Medicine, Krakow, Poland
3 Department of Pathology, The John Paul II Hospital, Krakow, Poland

Received 26 January 2007; revised 17 July 2007; accepted 26 July 2007.

* Corresponding author. Tel/fax: +48 12 633 67 44. E-mail address: prostoff{at}vp.pl

Aims: The incidence of diabetic cardiomyopathy, independent of arterial hypertension (AH) and coronary heart disease (CHD), remains controversial. The present study aimed to determine the influence of type 1 diabetes mellitus (T1DM) of long duration (>10 years) on myocardial function estimated by echocardiography (ECHO) and serum level of N-terminal pro-B type natriuretic peptide (NT-proBNP) in patients without CHD and AH. We also retrospectively investigated the relationship between the structural changes in the hearts of other deceased T1DM patients, and had their myocardial function echocardiographically assessed before death.

Methods and results: In 185 patients (96 males) with T1DM (mean duration 22.8 years) and 105 non-diabetic control subjects (57 males), detailed ECHO parameters and NT-proBNP were assessed. No significant differences were found between the respective groups. Histological studies of 17 hearts of deceased T1DM patients were carried out and retrospectively compared with their ECHO performed before death. Histological changes were identified, although without the signs of myocardial dysfunction on ECHO prior to death.

Conclusion: Even the application of echocardiographic, biochemical and morphologic techniques hardly gives sufficient grounds to believe that type 1 diabetes alone may actually precipitate myocardial dysfunction, despite long-term course of the disease and typical histological changes in the myocardium.

Key Words: Diabetic cardiomyopathy • Echocardiography • NT-proBNP • Autopsy reports • Type 1 diabetes mellitus


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
T. D. Karamitsos, A. Tsapas, and J. R. Arnold
Diabetic cardiomyopathy: a controversial entity
Eur. Heart J., February 2, 2008; 29(4): 564 - 564.
[Full Text] [PDF]


Home page
Eur Heart JHome page
E. Konduracka, A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, and W. Piwowarska
Diabetic cardiomyopathy: a controversial entity: reply
Eur. Heart J., February 2, 2008; 29(4): 565 - 565.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.